Glenn Larsen
Directeur/Membre du Conseil chez ANIKA THERAPEUTICS, INC.
Fortune : 777 785 $ au 31/05/2024
Profil
Glenn R.
Larsen is the founder of Aquinnah Pharmaceuticals, Inc. (founded in 2014) and 180 Therapeutics LP (founded in 2013), where he holds the titles of Chairman, President & Chief Executive Officer and Chairman, respectively.
Currently, he is an Independent Director at Anika Therapeutics, Inc. (since 2015).
Previously, he held Senior Director positions at Genetics Institute LLC (2003-2010) and COO, Director & Executive VP-Development positions at Hydra Biosciences, Inc. (2003-2010).
He was also a Vice President at Wyeth Pharmaceuticals LLC.
From 2010 to 2013, he was the CSO, Executive VP-Research & Development at SpringLeaf Therapeutics, Inc. Dr. Larsen holds a doctorate degree from Stony Brook University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANIKA THERAPEUTICS, INC.
0,20% | 17/05/2024 | 30 323 ( 0,20% ) | 777 785 $ | 31/05/2024 |
Postes actifs de Glenn Larsen
| Sociétés | Poste | Début |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/02/2015 |
Aquinnah Pharmaceuticals, Inc.
 Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Directeur Général | 01/02/2014 |
180 Therapeutics LP
 180 Therapeutics LP Pharmaceuticals: MajorHealth Technology Part of 180 Life Sciences Corp., 180 Therapeutics LP engages in the development of biological therapies for the treatment of fibrosis. The company is based in Cambridge, MA. The company was founded by Glenn R. Larsen. | Fondateur | 01/01/2013 |
Anciens postes connus de Glenn Larsen
| Sociétés | Poste | Fin |
|---|---|---|
SpringLeaf Therapeutics, Inc.
 SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | Directeur Technique/Scientifique/R&D | 01/01/2013 |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Directeur Technique/Scientifique/R&D | 01/01/2010 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/01/2010 |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
Formation de Glenn Larsen
| Stony Brook University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | Retail Trade |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
180 Therapeutics LP
180 Therapeutics LP Pharmaceuticals: MajorHealth Technology Part of 180 Life Sciences Corp., 180 Therapeutics LP engages in the development of biological therapies for the treatment of fibrosis. The company is based in Cambridge, MA. The company was founded by Glenn R. Larsen. | Health Technology |
